Indian biotechnology company and vaccine manufacturer
Bharat Biotech ▸ Facts ▸ Comments ▸ News ▸ Videos
Nurses share experience after administering COVID vaccine to PM Modi
Credit: ANI Duration: 01:16Published
PM Modi gets Covid-19 vaccine second dose, says 'if eligible, get your shot' | Oneindia News
Credit: Oneindia Duration: 01:11Published
Watch: PM Modi receives second dose of Covid vaccine; nurses share experience
Credit: HT Digital Content Duration: 02:24Published
PM Modi takes 2nd jab of COVID-19 vaccine at AIIMS
Credit: ANI Duration: 01:26Published
Covid: Delhi Dy CM gets first vaccine jab as capital faces infection surge
Credit: HT Digital Content Duration: 03:49Published
Watch: Harsh Vardhan takes 2nd dose of Covaxin, says 7 more vaccines in trials
Credit: HT Digital Content Duration: 05:01Published
‘India doing its best…’: Costa Rica, Paraguay request COVAXIN supply
Credit: HT Digital Content Duration: 03:49Published
Watch: Ramdas Athawale, his wife take first shot of Covid-19 vaccine in Mumbai
Credit: HT Digital Content Duration: 01:44Published
Union Minister Ramdas Athawale takes first covid vaccine
Credit: ANI Duration: 01:22Published
Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News
Credit: Oneindia Duration: 02:43Published
'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech
Credit: ANI Duration: 01:42Published
Covid-19 vaccination drive 2.0: PM Modi takes Covaxin shot, what does it mean? | Oneindia News
Credit: Oneindia Duration: 04:14Published
Covid vaccine: How to register, where to go, what you need | All key details
Credit: HT Digital Content Duration: 04:31Published
Controversy of 'comparing vaccines' laid to rest: AIIMS Director on PM taking COVID shot
Credit: ANI Duration: 01:26Published
Ministers decided to avail paid COVID vaccination facility: RS Prasad
Credit: ANI Duration: 01:45Published
You Might Like
Even as Covid vaccine demand rises, firms may take some weeks to up productionIndications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and Bharat Biotech ramp up capacity, some of..
PM Modi receives second dose of COVID-19 vaccine at AIIMSEarlier, on March 1, PM Modi had taken the first dose of Bharat Biotech's Covaxin at AIIMS Delhi
Covid-19: Government's expert panel allows clinical trials for third dose of CovaxinBharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial protocol for administration of booster dose..
Why Brazil has denied permission to import Bharat Biotech's Covaxin
Bharat Biotech, Biovet, Sapigen Biologix sign collaborative research agreement with CSIR-IICTBharat Biotech International, Biovet, and Sapigen Biologix will identify mutually interesting projects to pursue under the agreement.
Govt raises gap between Covishield shots to 4-8 weeksThe health ministry on Monday revised the interval between two doses of the Covishield vaccine to 4-8 weeks, from the existing 4-6 weeks, after evidence showed higher efficacy following a longer gap..
Increase gap between two doses of Covishield to 6-8 weeks, Centre tells statesThe Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8 weeks from the current 28 days.The Centre..
Covaxin out of clinical trial mode, granted restricted emergency use authorisationThe Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular restricted emergency use authorisation just..
Expert panel recommends dropping ‘clinical trial mode’ tag for CovaxinIn a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator's subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial..
CDSCO expert panel recommends Covaxin be moved out of 'clinical trial mode'An expert panel of India's central drugs authority on Wednesday recommended granting emergency use authorisation to Bharat Biotech's indigenously developed Covaxin while removing the condition for the..
Lancet publishes Covaxin phase 2 trials dataprestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens between Phase 1 (two doses given 2 weeks..
Mexico experts recommend approving Indian vaccineA technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company Bharat Biotech. The report by the..
Delhi high court asks Serum Institute, Bharat Biotech to disclose capacity to manufacture Covid-19 vaccines"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So there has to be that sense of responsibility..
Covaxin shows 81% efficacy, say ICMR and Bharat BiotechThis interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical Research (ICMR), said in a statement. The..
Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 resultsCovaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January.
Bharat Biotech announces Phase 3 results: All you need to know
Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech
PM Modi takes the shot, gives vaccine process a booster doseThe PM, who is 70, was administered Covaxin, the indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). This decision too seemed deliberate..
Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm
Bharat Biotech hails PM Modi for taking Covid-19 vaccine, says it will give a huge boost to immunisation campaign
PM Modi sends out key message as he takes Covaxin shotPrime Minister Narendra Modi was administered the first dose of Covid-19 vaccine on Monday. Among the two vaccines available in India, PM Modi was administered the Bharat Biotech's Covaxin, developed..
'Powerful example for all Indians': Bharat Biotech after PM Modi takes Covaxin shotPrime Minister Narendra Modi on Monday (March 1) was administered the first dose of COVID-19 vaccine, Covaxin at the AIIMS, Delhi.
'Pata hi nahi chala': PM Modi on taking the first shot of COVID-19 vaccinePM Modi was administered Covaxin, developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research.
Covid-19: Bharat Biotech to supply 20 million doses of Covaxin to Brazil
Brazil to buy 20 million Covid-19 vaccines from India's Bharat BiotechBrazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery between March and May. The ministry..
Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data
Covaxin trials for kids likely soon in NagpurBharat Biotech, makers of indigenous Covid-19 vaccine Covaxin, is expected to start vaccine trial for children by February-end or early March this year. As per international regulations, only vaccines..
Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in PhilippinesNew Delhi has gifted India-made Covishield vaccine of Oxford-AstraZeneca made by Serum Institute of India to 10 countries.
Bharat Biotech in pact with GSK, PATH to manufacture world's only malaria vaccine
Covaxin effectively neutralises UK variants: Bharat BiotechIndia's first indigenous Covid-19 vaccine Covaxin effectively neutralises the deadly and infectious UK variants of SARS-CoV-2 virus, reducing the possibility of mutant virus escape, its developer..
Pfizer wants India to order Covid-19 vaccine before pursuing approvalPfizer Inc will pursue its request for India to approve its Covid-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten. Pfizer..
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet studyIndia's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the..
Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccineAn expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech,..
Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of CovaxinBharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. Out of the 45 lakh doses, the city-based vaccine..
COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns growBharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
COVID-19: Bharat Biotech to pay compensation for any side effect of Covaxin, details hereBharat Biotech, has received a government purchase order for the supply of 55 lakh doses of Covaxin.
Compensation if Covaxin causes serious adverse effectBeneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally related to the vaccine. Beneficiaries of..
India plans 20 million doses of vaccine supply to neighboursIndia plans to offer 20 million doses of coronavirus vaccine to its neighbours as it draws up a policy to supply vials to countries across the globe, people with knowledge of the matter said. An Indian..
Experts question govt vaccine purchase price, say it’s higherAs the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s..
Vaccine drive accelerates, doses reach far corners of IndiaWhile SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
Bharat Biotech commences dispatch of Covaxin, ships to 11 citiesVaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown out of Hyderabad by national carrier..
After Covishield, first batch of Bharat Biotech's Covaxin arrives in DelhiBoth Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government.
Covid vaccine recipients may not be able to pick & chooseEven as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they..
Bharat Biotech inks pact to supply Covaxin to BrazilVaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian..
54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: CentreThe Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of..
Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-MarchBuoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new..
Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccinesVaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of Covid-19 vaccines in the country and the world.
Why Covaxin may have an edge against new virus variantsThe chairman and managing director of Bharat Biotech, Dr Kishna Ella, said its Covid-19 vaccine, Covaxin, would be effective on mutant strains of the coronavirus, and therefore is justified to receive..